NanoXplore Valuation

Is GRA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GRA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GRA (CA$2.21) is trading above our estimate of fair value (CA$1.68)

Significantly Below Fair Value: GRA is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for GRA?

Key metric: As GRA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GRA. This is calculated by dividing GRA's market cap by their current revenue.
What is GRA's PS Ratio?
PS Ratio2.8x
SalesCA$134.72m
Market CapCA$387.28m

Price to Sales Ratio vs Peers

How does GRA's PS Ratio compare to its peers?

The above table shows the PS ratio for GRA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.6x
CHE.UN Chemtrade Logistics Income Fund
0.8x0.7%CA$1.4b
BOS AirBoss of America
0.2x9.0%CA$114.8m
MX Methanex
0.8x10.6%CA$4.2b
IFOS Itafos
0.5xn/aCA$334.1m
GRA NanoXplore
2.8x24.7%CA$387.3m

Price-To-Sales vs Peers: GRA is expensive based on its Price-To-Sales Ratio (2.8x) compared to the peer average (0.6x).


Price to Sales Ratio vs Industry

How does GRA's PS Ratio compare vs other companies in the CA Chemicals Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
BOS AirBoss of America
0.2x9.0%US$82.08m
PRH Pearl River Holdings
0.08xn/aUS$2.93m
GDNP.H good natured Products
0.03xn/aUS$1.31m
No more companies available in this PS range
GRA 2.8xIndustry Avg. 0.9xNo. of Companies6PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: GRA is expensive based on its Price-To-Sales Ratio (2.8x) compared to the Canadian Chemicals industry average (0.9x).


Price to Sales Ratio vs Fair Ratio

What is GRA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GRA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.8x
Fair PS Ratio1.5x

Price-To-Sales vs Fair Ratio: GRA is expensive based on its Price-To-Sales Ratio (2.8x) compared to the estimated Fair Price-To-Sales Ratio (1.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GRA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCA$2.21
CA$4.57
+106.7%
33.9%CA$8.45CA$3.25n/a8
Nov ’25CA$2.41
CA$4.60
+90.9%
33.2%CA$8.45CA$3.25n/a8
Oct ’25CA$2.20
CA$4.60
+109.1%
33.2%CA$8.45CA$3.25n/a8
Sep ’25CA$2.25
CA$4.88
+116.7%
44.7%CA$10.50CA$3.25n/a8
Aug ’25CA$2.44
CA$4.88
+99.8%
44.7%CA$10.50CA$3.25n/a8
Jul ’25CA$2.47
CA$4.91
+98.6%
44.1%CA$10.50CA$3.25n/a8
Jun ’25CA$2.68
CA$4.91
+83.1%
44.1%CA$10.50CA$3.25n/a8
May ’25CA$2.48
CA$4.11
+65.6%
12.1%CA$5.00CA$3.25n/a7
Apr ’25CA$2.56
CA$3.96
+54.9%
8.5%CA$4.50CA$3.25n/a7
Mar ’25CA$2.71
CA$3.91
+44.1%
9.0%CA$4.50CA$3.25n/a8
Feb ’25CA$2.12
CA$4.00
+88.7%
8.8%CA$4.50CA$3.25n/a7
Jan ’25CA$2.43
CA$4.81
+98.0%
45.2%CA$10.50CA$3.25n/a8
Dec ’24CA$2.04
CA$5.04
+146.8%
44.4%CA$10.50CA$4.00n/a7
Nov ’24CA$2.17
CA$6.46
+197.9%
60.6%CA$16.00CA$4.00CA$2.417
Oct ’24CA$2.62
CA$6.61
+152.2%
58.2%CA$16.00CA$4.50CA$2.207
Sep ’24CA$3.03
CA$6.71
+121.6%
56.8%CA$16.00CA$4.50CA$2.257
Aug ’24CA$3.09
CA$6.71
+117.3%
56.8%CA$16.00CA$4.50CA$2.447
Jul ’24CA$3.24
CA$6.71
+107.2%
56.8%CA$16.00CA$4.50CA$2.477
Jun ’24CA$2.75
CA$7.00
+154.5%
57.9%CA$16.00CA$4.50CA$2.686
May ’24CA$3.02
CA$7.29
+141.4%
53.6%CA$16.00CA$5.00CA$2.486
Apr ’24CA$3.26
CA$7.25
+122.4%
49.9%CA$16.00CA$5.00CA$2.567
Mar ’24CA$3.00
CA$6.39
+113.1%
24.7%CA$10.00CA$5.00CA$2.717
Feb ’24CA$2.95
CA$6.54
+121.5%
23.5%CA$10.00CA$5.00CA$2.127
Jan ’24CA$2.60
CA$6.82
+162.4%
23.4%CA$10.00CA$5.00CA$2.437
Dec ’23CA$2.78
CA$7.36
+164.6%
37.7%CA$13.75CA$5.00CA$2.047
Nov ’23CA$3.35
CA$8.22
+145.4%
31.4%CA$13.75CA$6.00CA$2.177

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies